Demo

3676 Articles Matching "drugs"

Prices of MS Medications Keep Soaring

Jan 17, 2020 , WebMD
Medicaid spending on 15 MS drugs increased from $453 million to just over $1.3 billion between 2011 and...
Read more

New Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?

Jan 16, 2020 , MedicineNet
Title: New Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?Category: Health NewsCreated: 1/14/2020 12:00:00 AMLast Editorial Review: 1/15/2020 12:00:00...
Read more

New Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?

Jan 16, 2020 , WebMD
The result is that patients are being prescribed pricey new medications that have not been tested as rigorously, said lead researcher Jonathan Darrow, an assistant professor at Harvard Medical...
Read more

A Pharma Snapshot Of JP Morgan Conference: Bristol’s Love Story, Alzheimer’s Drugs’ Future, Gilead’s Crown Jewels

Jan 16, 2020 , Kaiser Health News
Stat offers a glimpse into what pharmaceutical companies are buzzing about at the big annual J.P. Morgan Healthcare Conference in San Francisco. Also on the docket: what role tech will play in the future of the industry, the promise of immunotherapies, "smart pills," and...
Read more

What Works Best to Help Men With Overactive Bladder?

Jan 15, 2020 , WebMD
A combination of drugs and behavioral therapy seems to work better than drugs alone, but behavioral therapy alone also worked better than drugs, the researchers...
Read more
Demo

A Pharma Startup Launches With $200 Million In Funding And A Strategy To Make Drugs Faster, Cheaper

Jan 13, 2020 , Forbes
EQRx, a new pharmaceutical startup from biotech entrepreneur Alexis Borisy, wants to make drugs faster and cheaper than traditional pharma companies....
Read more

Walgreens Sees More Doctors Connected To Its Drugstores

Jan 10, 2020 , Forbes
Though two partnerships Walgreens has to strengthen the drugstore chain’s relationships with physicians remain in testing stages, company executives say they are performing well and a future expansion could be around the...
Read more

Bristol-Myers confident of approvals linked to higher Celgene investor payout: Bristol executive

Jan 10, 2020 , Reuters
Bristol-Myers Squibb Co is confident it will receive U.S. approvals for all three experimental drugs tied to a potentially higher payout for Celgene shareholders under terms of its acquisition of the U.S. biotech company, Bristol's chief medical officer said....
Read more

Pilot study of Asian genomes finds novel gene variants, highlights diversity

Jan 10, 2020 , Reuters
(Reuters Health) - An effort to map genomes across Asia has the potential to find novel gene variants affecting disease and responses to drugs, and to reveal the complex origins of Asian populations, early results suggest....
Read more

Amag to divest two of three women's health drugs, CEO to step down

Jan 10, 2020 , Reuters
Amag Pharmaceuticals Inc said on Thursday chief executive officer would step down and it plans to divest two of its women's health drugs, bowing to pressure from investor Caligan Partners that has long urged it to hive off the slow-growing unit....
Read more

Focus Needed Not Just On Drugs But Hospital Expenses To Impact Healthcare Costs

Jan 09, 2020 , Forbes
Despite the fact that hospital costs are the biggest part of our health care system and that such costs are growing more rapidly than other health care segments, politicians find it easier to go after biopharma companies....
Read more
A demo

Walgreens first-quarter profit falls nearly 25% on higher costs

Jan 09, 2020 , Reuters
Drugstore chain Walgreens Boots Alliance Inc posted a 24.8% drop in quarterly profit on Wednesday, hurt by higher costs related to its acquisition of stores from rival Rite Aid Corp...
Read more

Walgreens Mum On Buyout As Profits Fall 25%

Jan 09, 2020 , Forbes
Walgreens Boots Alliance profits dipped in the company’s fiscal first quarter as the company works to reinvent its U. S. drugstores amid rumors the the global chain may be taken private in a massive leveraged...
Read more

Walgreens' shares fall 5% on earnings miss as pharmacy chain grapples with more competition

Jan 09, 2020 , CNBC Health
Walgreens remains under pressure as more consumers shop online for drugstore staples such as shampoo and...
Read more

Bloody Philippine drug war fails to curb methamphetamine supply: VP

Jan 07, 2020 , Reuters
Philippine President Rodrigo Duterte's war on drugs has only managed to curb the supply of methamphetamines by less than 1% of annual consumption, proof that it has been a bloody failure, his main political rival, the vice president, said on Monday....
Read more

Explainer: Making a new generation of 'guided-missile' cancer drugs work

Jan 07, 2020 , Reuters
A class of treatments known as antibody-drug conjugates (ADC) combine cancer-tracking proteins with powerful cell toxins. The therapies are getting a fresh start as dozens of drugmakers test a record number of new compounds in people....
Read more

The Financial Impossibilities Of Making Antibiotics: Why Drugmakers Are Going Bust Even In Era Of Superbugs

Jan 07, 2020 , Kaiser Health News
Doctors are prescribing the drugs sparingly and patients only need to take them a week or two at a time. In a world where pricey million-dollar cancer drugs are king, drugmakers producing modest antibiotics are crashing just when the country needs them the most. In other pharmaceutical news: pay-to-delay deals, blockbuster treatments and a failed...
Read more

Drug developers take fresh aim at 'guided-missile' cancer drugs

Jan 07, 2020 , Reuters
Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer, evidence of renewed confidence in an approach that has long fallen short of its promise, an analysis compiled for Reuters shows....
Read more

Novartis, Merck and Allergan join those raising U.S. drug prices for 2020

Jan 04, 2020 , Reuters
Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on Friday, bringing the tally to 445 drugs that will cost more in 2020, according to data analyzed by healthcare research firm 3 Axis Advisors....
Read more

More January U.S. price hikes take 2020 tally to over 330 drugs with higher cost

Jan 03, 2020 , Reuters
AbbVie Inc on Thursday raised the cost of rheumatoid arthritis treatment Humira, the world's top-selling medicine, joining other drugmakers that have now hiked U.S. prices of more than 330 prescription drugs for 2020, according to data analyzed by healthcare research firm 3 Axis Advisors....
Read more